By Omar Ford, Staff Writer The U.S. Federal Trade Commission (FTC) has approved Abbott Laboratories' $25 billion acquisition of St. Jude Medical Inc. The deal was green lit after the FTC accepted a proposal for the divestiture of St. Jude's vascular closure device business and Abbott's steerable sheath business to Terumo Corp. Abbott first made a bid to acquire St. Paul, Minn.-based St. Jude earlier this year. (See Medical Device Daily, April 29, 2016.) The proposed deal drew concern from federal antitrust regulators, who said the combined company would control a significant percentage of the vascular closure device market. The...

Endologix Inc. has resumed shipping of some of its AFX endovascular abdominal aortic aneurysm systems, after placing the devices on hold. This brought an end to a rather tumultuous week for the Irvine, Calif.-based company's stock (NASDAQ: ELGX), which plummeted as much as 27 percent upon news of the hold. However, shares of the stock slightly rebounded late last week. (See Medical Device Daily, Dec. 28, 2016.) In the second of two calls held over a four-day period, Endologix provided an update on developments in the AFX product line. Endologix noted the temporary hold stems...

There's no question that both 2015 and 2016 were blockbuster years for surgical sealant maker Cohera Medical Inc. During the two-year period, the company brought in significant funding and received its first FDA device approval. The private company is getting off to a strong start in 2017 with the enrollment of the first patient in the clinical trial for the Sylys surgical sealant. The company said Sylys will serve as an adjunct to standard closure techniques in colorectal and ileorectal anastomosis procedures.

Endologix Inc. has resumed shipping of some of its AFX endovascular abdominal aortic aneurysm systems, after placing the devices on hold. This brought an end to a rather tumultuous week for the Irvine, Calif.-based company's stock (NASDAQ: ELGX), which plummeted as much as 27 percent upon news of the hold. However, shares of the stock slightly rebounded late last week. (See Medical Device Daily, Dec. 28, 2016.)

The U.S. Federal Trade Commission (FTC) has approved Abbott Laboratories' $25 billion acquisition of St. Jude Medical Inc. The deal was green lit after the FTC accepted a proposal for the divestiture of St. Jude's vascular closure device business and Abbott's steerable sheath business to Terumo Corp.

Oncology specialist Varian Medical Systems Inc. has agreed to acquire the medical imaging business of Perkinelmer Inc. for $276 million, incorporating it into Varex Imaging Corp., a publicly traded spin-off set to launch next month.